Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cholane derivatives for use in the treatment and/or prevention of FXR and TGR5/GPBAR1 mediated diseases

Cholane derivatives for use in the treatment and/or prevention of FXR and TGR5/GPBAR1 mediated diseases

US Patent 11117926 · Granted Sep 14, 2021

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Isoxazole as FXR receptor agonists2022
Isoxazole as FXR receptor agonists2022
Treatment of fibrosis using FXR ligands2021
Cholane derivatives for use in the treatment and/or prevention of FXR and TGR5/G2019
Cholane derivatives for use in the treatment and/or prevention of FXR and TGR5/G2019
Treatment of fibrosis using FXR ligands2019
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-medi2017
Treatment of fibrosis using FXR ligands2016
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-medi2015
Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-medi2013
Derivatives of 4- or 5-aminosalicylic acid2012
Derivatives of 4- or 5-aminosalicylic acid2012